iShares Neuroscience and Healthcare ETF Rating → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IBRN Stock Alerts $24.26 +0.22 (+0.92%) (As of 05/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy2.71Holdings in IBRN have an aggregate rating of Moderate Buy based on 330 analyst ratings issued in the past year covering 42 companies (86.8% of the portfolio).IBRN Aggregate Price Target$39.9964.86% UpsideHigh Prediction$51.76Average Prediction$39.99Low Prediction$29.78Holdings in IBRN have an aggregate price target of $39.99 and a range of $29.78 to $51.76 covering 42 companies (86.8% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy23 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 IBRN Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.92%CERECerevel Therapeutics$42.26-0.6%0 of 5 stars2.11$42.67 1.0%9Upcoming EarningsPositive News4.84%NBIXNeurocrine Biosciences$143.19+1.0%5 of 5 stars2.74$147.88 3.3%23Analyst RevisionNews Coverage4.83%ITCIIntra-Cellular Therapies$71.21+0.3%5 of 5 stars2.90$90.17 26.6%10Analyst ForecastNews Coverage4.74%AXNXAxonics$67.38-0.3%3 of 5 stars2.38$70.73 5.0%13Earnings ReportAnalyst Forecast4.37%ARGXargenx$398.81+1.3%3 of 5 stars2.71$528.16 32.4%21Upcoming Earnings4.34%SRPTSarepta Therapeutics$136.04+0.7%4 of 5 stars2.79$160.60 18.1%14Earnings ReportInsider SellingAnalyst Revision4.21%IARTIntegra LifeSciences$25.08+8.4%5 of 5 stars2.00$36.80 46.7%11Earnings ReportAnalyst DowngradeNews CoverageGap DownHigh Trading Volume4.13%BIIBBiogen$218.92-1.1%5 of 5 stars2.65$290.92 32.9%264.12%XENEXenon Pharmaceuticals$43.43+0.6%3 of 5 stars3.00$59.44 36.9%9Upcoming Earnings4.08%BHVNBiohaven$41.49+0.7%3 of 5 stars3.00$52.13 25.6%8Upcoming Earnings3.77%ALKSAlkermes$24.59+2.0%5 of 5 stars2.50$35.38 43.9%10Earnings ReportAnalyst Revision3.70%PTCTPTC Therapeutics$31.79-3.5%2 of 5 stars1.92$33.67 5.9%13Positive News3.41%ACADACADIA Pharmaceuticals$17.25+1.5%4 of 5 stars2.80$31.75 84.1%15Upcoming EarningsAnalyst Forecast3.22%CPRXCatalyst Pharmaceuticals$15.14+1.0%5 of 5 stars3.00$26.43 74.6%53.17%SUPNSupernus Pharmaceuticals$31.15+2.4%4 of 5 stars3.00$41.00 31.6%13.08%AVDLAvadel Pharmaceuticals$18.18-2.4%3 of 5 stars3.00$23.67 30.2%6Upcoming Earnings2.00%PRTAProthena$23.54-0.8%2 of 5 stars2.71$68.14 189.5%7News Coverage1.97%DYNDyne Therapeutics$25.65-2.3%3 of 5 stars3.13$37.75 47.2%8Analyst Forecast1.95%EWTXEdgewise Therapeutics$21.23+4.4%1 of 5 stars3.00$31.20 47.0%5Upcoming Earnings1.74%SAVACassava Sciences$21.83+1.4%3 of 5 stars3.00$124.00 468.0%11.58%SRRKScholar Rock$14.69-2.5%5 of 5 stars3.17$25.17 71.3%6Upcoming EarningsAnalyst ForecastNews Coverage1.22%LBPHLongboard Pharmaceuticals$22.05+7.0%3 of 5 stars3.00$43.67 98.1%6Analyst ForecastNews Coverage1.04%NMRANeumora Therapeutics$9.81+4.9%1 of 5 stars2.86$22.57 130.1%70.91%NVRONevro$11.53+3.4%2 of 5 stars2.00$21.23 84.1%13News Coverage0.86%WVEWave Life Sciences$5.79+0.7%5 of 5 stars2.71$10.14 75.2%7Upcoming EarningsNews Coverage0.75%ALECAlector$5.30-0.4%3 of 5 stars2.57$14.86 180.3%7Upcoming Earnings0.69%DNTHDianthus Therapeutics$24.04+0.5%1 of 5 stars3.00$42.40 76.4%50.68%VYGRVoyager Therapeutics$8.77-1.9%4 of 5 stars2.86$19.33 120.4%7Upcoming Earnings0.66%KYTXKyverna Therapeutics$13.65-2.2%2 of 5 stars3.00$42.75 213.2%5Gap Down0.63%AVXLAnavex Life Sciences$3.843 of 5 stars3.00$40.00 941.7%1Upcoming Earnings0.61%PEPGPepGen$13.96+0.1%3 of 5 stars3.00$24.67 76.7%2Upcoming EarningsPositive News0.58%SLDBSolid Biosciences$10.42+4.2%3 of 5 stars3.00$18.25 75.1%6Upcoming Earnings0.58%ANNXAnnexon$4.73-1.7%3 of 5 stars3.00$14.43 205.0%6Upcoming Earnings0.56%AXGNAxoGen$5.83+2.8%2 of 5 stars3.00$10.67 83.0%3Analyst DowngradeNews Coverage0.51%ANROAlto Neuroscience$15.01+5.0%2 of 5 stars3.00$32.33 115.4%5Negative News0.45%TRDAEntrada Therapeutics$13.88+2.8%2 of 5 stars3.00$21.00 51.3%2Upcoming EarningsNews CoverageGap Up0.37%ABEOAbeona Therapeutics$4.56-4.6%4 of 5 stars3.00$36.00 689.5%1Upcoming Earnings0.35%LRMRLarimar Therapeutics$8.13-1.3%3 of 5 stars3.00$18.50 127.6%6News Coverage0.32%NPCENeuroPace$13.30-1.3%1 of 5 stars2.86$15.67 17.8%70.32%CVRXCVRx$8.10+1.6%4 of 5 stars2.67$16.60 104.9%6High Trading Volume0.30%CAPRCapricor Therapeutics$5.46-1.3%1 of 5 stars3.00$24.00 339.6%2Upcoming EarningsNews Coverage0.28%ABOSAcumen Pharmaceuticals$3.36-5.6%2 of 5 stars3.00$12.25 264.6%5Upcoming EarningsNews CoveragePositive News This page (NYSEARCA:IBRN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow Investor[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
